AZGP1 antibody (N-Term)
Quick Overview for AZGP1 antibody (N-Term) (ABIN634659)
Target
See all AZGP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- AZGP1 antibody was raised against the N terminal of AZGP1
-
Purification
- Affinity purified
-
Immunogen
- AZGP1 antibody was raised using the N terminal of AZGP1 corresponding to a region with amino acids KVAQYMADVLEDSKDKVQENLLANGVDLVTYITRFQWDMAKYPIKQSLKN
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
AZGP1 Blocking Peptide, (ABIN940086), is also available for use as a blocking control in assays to test for specificity of this AZGP1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AZGP1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))
-
Alternative Name
- AZGP1
-
Background
- Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. AZGP1 may bind polyunsaturated fatty acids.
-
Molecular Weight
- 33 kDa (MW of target protein)
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-